iShares US Medical Devices ETF
583 hedge funds and large institutions have $2.33B invested in iShares US Medical Devices ETF in 2024 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 164 increasing their positions, 230 reducing their positions, and 49 closing their positions.
110% more call options, than puts
Call options by funds: $45.7M | Put options by funds: $21.7M
37% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 49
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
7% more capital invested
Capital invested by funds: $2.19B → $2.33B (+$145M)
1% more funds holding
Funds holding: 576 → 583 (+7)
0.22% less ownership
Funds ownership: 40.67% → 40.46% (-0.22%)
29% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 230
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$293M |
| 2 |
Barclays
London,
United Kingdom
|
+$19.6M |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$10.7M |
| 4 |
Goldman Sachs
New York
|
+$10.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.3M |
Top Sellers
IHI Hedge Fund Activity: Q1 2024 in Review
583 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q1 2024, worth a combined $2.33B — up 6.6% from $2.19B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new IHI positions and 49 closed out — a net gain of 18 holders — while 164 added to existing stakes and 230 trimmed.
The largest buyer was Citigroup, adding an estimated $293M. The largest seller was Meitav Investment House, exiting entirely with an estimated $166M sold.
- 583 institutional investors held iShares US Medical Devices ETF (IHI) as of Q1 2024, up from 576 in Q4 2023.
- Funds reported $2.33B of iShares US Medical Devices ETF stock for Q1 2024, up 6.6% quarter-over-quarter.
- 67 funds opened new iShares US Medical Devices ETF positions in Q1 2024 and 49 closed out, a net change of +18 holders.
- The largest iShares US Medical Devices ETF buyer in Q1 2024 was Citigroup, an estimated $293M added.
- The largest iShares US Medical Devices ETF seller in Q1 2024 was Meitav Investment House, an estimated $166M sold.
Based on aggregated 13F filings for Q1 2024.